Xinyu M. Su

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Rhodium-catalyzed enantioselective intermolecular C-H silylation of simple arenes: synergistic substituent effects overcome silane redistribution to enable synthesis of Si-stereogenic arylsilanes.

Rhodium-catalyzed enantioselective intermolecular C-H silylation of simple arenes: synergistic substituent effects overcome silane redistribution to enable synthesis of Si-stereogenic arylsilanes.

Journal: Chemical science
Published: February 17, 2026

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer
Published: January 27, 2026

A single-center 3D reconstruction image dataset for exploring inferior mesenteric artery and vein types.

A single-center 3D reconstruction image dataset for exploring inferior mesenteric artery and vein types.

Journal: Scientific data
Published: September 15, 2025

Characteristics of cancer mycobiome in patients with acral melanoma.

Characteristics of cancer mycobiome in patients with acral melanoma.

Journal: Journal for immunotherapy of cancer
Published: June 24, 2025

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer
Published: June 08, 2025

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Journal: Cancer immunology, immunotherapy : CII
Published: January 19, 2025

C-Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration.

C-Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration.

Journal: Cancer medicine
Published: December 12, 2024

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Journal: NPJ precision oncology
Published: September 25, 2024

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Journal: Journal for immunotherapy of cancer
Published: March 29, 2024

KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.

KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.

Journal: BMC cancer
Published: December 20, 2023

Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.

Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma.

Journal: Scientific reports
Published: December 12, 2023

Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.

Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.

Journal: Cancer medicine
Published: November 16, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026